Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
暂无分享,去创建一个
M. Schindler | K. Wiesmüller | M. Bitzer | N. Schneiderhan-Marra | J. Walz | N. Ruétalo | M. Denk | C. Meisner | J. Heitmann | Imma Fischer | Claudia Tandler | Hans-Georg Rammensee | S. Jaeger | M. Oezbek | M. Marconato | Marion Richter | Christoph Meisner | T. M. Michael | S. Schroeder | Y. Maringer | H. Salih | C. Tandler | M. Richter | I. Fischer | C. M. Tegeler | K. Wiesmueller | Michael Bitzer | Michael Schindler | H. Rammensee | Tanja M. Michel | Simon U. Jaeger | M. T. Oezbek | Sarah M Schroeder